Nigeria, Oct. 24 -- The World Health Organisation (WHO) has announced the commencement of a new Ebola vaccine trial in the Democratic Republic of the Congo (DRC), as health authorities seek to establish whether existing and experimental vaccines can protect against the Bundibugyo strain of the virus.

WHO Director-General, Tedros Ghebreyesus, disclosed this in a statement posted on his official X account on Friday, announcing that the first participants had been vaccinated in Bunia, eastern DRC.

The trial, named Tumaini, which means "hope" in Swahili, will assess vaccine candidates designed to protect against the Bundibugyo virus, for which no vaccine has been approved.

"Science gives us hope," Mr Ghebreyesus said, describing the trial ...